Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

Yuzhen Yin,1 Hui Yang,2 Zhuo Liu,3 Jie Tan,2 Chunrong Zhu,4 Minbin Chen,5 Rengui Zhou,6 Lei Wang,7 Jun Qian2,8 1Department of Tumor Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, Jiangsu, People’s Republic of China; 2Department of Oncology, Suzhou Mu...

Full description

Bibliographic Details
Main Authors: Yin Y, Yang H, Liu Z, Tan J, Zhu C, Chen M, Zhou R, Wang L, Qian J
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Cancer Management and Research
Subjects:
pyrotinib
her2-positive
solid tumor
Online Access:https://www.dovepress.com/studies-on-the-safety-and-efficacy-of-pyrotinib-in-the-treatment-of-he-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/studies-on-the-safety-and-efficacy-of-pyrotinib-in-the-treatment-of-he-peer-reviewed-article-CMAR

Similar Items